[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

D-Mannose Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

November 2020 | 111 pages | ID: D8D5E081F073EN
99Strategy

US$ 2,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary

The global D-Mannose market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global D-Mannose market segmented into
  • Tablet (including dispersible tablet and general tablet)
  • Purity 99.0%
  • Others
Based on the end-use, the global D-Mannose market classified into
  • Tablet (including dispersible tablet and general tablet)
  • Capsule
  • Others
Based on geography, the global D-Mannose market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • AstraZeneca
  • Teva Pharmaceutical Industries
  • MSN Laboratories
  • Cadila Pharmaceuticals
  • LGM Pharma
  • Bal Pharma
  • Changzhou Pharmaceutical Factory
  • Jingxin Pharm
  • Zhejiang Hisun Pharmaceutical
  • HEC Pharm
  • Lunan Pharmaceutical
  • Nanjing Frochem Tech
  • Lianyungang Runzhong Pharmaceutical
  • Shandong Bechem Chemicals
  • CTX Life Sciences
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL D-MANNOSE INDUSTRY

2.1 Summary about D-Mannose Industry
2.2 D-Mannose Market Trends
  2.2.1 D-Mannose Production & Consumption Trends
  2.2.2 D-Mannose Demand Structure Trends
2.3 D-Mannose Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Purity 98.0%
  4.2.2 Purity 99.0%
  4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Tablet (including dispersible tablet and general tablet)
  4.3.2 Capsule
  4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Purity 98.0%
  5.2.2 Purity 99.0%
  5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Tablet (including dispersible tablet and general tablet)
  5.3.2 Capsule
  5.3.3 Others
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Purity 98.0%
  6.2.2 Purity 99.0%
  6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Tablet (including dispersible tablet and general tablet)
  6.3.2 Capsule
  6.3.3 Others
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Purity 98.0%
  7.2.2 Purity 99.0%
  7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Tablet (including dispersible tablet and general tablet)
  7.3.2 Capsule
  7.3.3 Others
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Purity 98.0%
  8.2.2 Purity 99.0%
  8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Tablet (including dispersible tablet and general tablet)
  8.3.2 Capsule
  8.3.3 Others
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Purity 98.0%
  9.2.2 Purity 99.0%
  9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Tablet (including dispersible tablet and general tablet)
  9.3.2 Capsule
  9.3.3 Others
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 AstraZeneca
  10.1.2 Teva Pharmaceutical Industries
  10.1.3 MSN Laboratories
  10.1.4 Cadila Pharmaceuticals
  10.1.5 LGM Pharma
  10.1.6 Bal Pharma
  10.1.7 Changzhou Pharmaceutical Factory
  10.1.8 Jingxin Pharm
  10.1.9 Zhejiang Hisun Pharmaceutical
  10.1.10 HEC Pharm
  10.1.11 Lunan Pharmaceutical
  10.1.12 Nanjing Frochem Tech
  10.1.13 Lianyungang Runzhong Pharmaceutical
  10.1.14 Shandong Bechem Chemicals
  10.1.15 CTX Life Sciences
10.2 D-Mannose Sales Date of Major Players (2017-2020e)
  10.2.1 AstraZeneca
  10.2.2 Teva Pharmaceutical Industries
  10.2.3 MSN Laboratories
  10.2.4 Cadila Pharmaceuticals
  10.2.5 LGM Pharma
  10.2.6 Bal Pharma
  10.2.7 Changzhou Pharmaceutical Factory
  10.2.8 Jingxin Pharm
  10.2.9 Zhejiang Hisun Pharmaceutical
  10.2.10 HEC Pharm
  10.2.11 Lunan Pharmaceutical
  10.2.12 Nanjing Frochem Tech
  10.2.13 Lianyungang Runzhong Pharmaceutical
  10.2.14 Shandong Bechem Chemicals
  10.2.15 CTX Life Sciences
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table D-Mannose Product Type Overview
2.Table D-Mannose Product Type Market Share List
3.Table D-Mannose Product Type of Major Players
4.Table Brief Introduction of AstraZeneca
5.Table Brief Introduction of Teva Pharmaceutical Industries
6.Table Brief Introduction of MSN Laboratories
7.Table Brief Introduction of Cadila Pharmaceuticals
8.Table Brief Introduction of LGM Pharma
9.Table Brief Introduction of Bal Pharma
10.Table Brief Introduction of Changzhou Pharmaceutical Factory
11.Table Brief Introduction of Jingxin Pharm
12.Table Brief Introduction of Zhejiang Hisun Pharmaceutical
13.Table Brief Introduction of HEC Pharm
14.Table Brief Introduction of Lunan Pharmaceutical
15.Table Brief Introduction of Nanjing Frochem Tech
16.Table Brief Introduction of Lianyungang Runzhong Pharmaceutical
17.Table Brief Introduction of Shandong Bechem Chemicals
18.Table Brief Introduction of CTX Life Sciences
19.Table Products & Services of AstraZeneca
20.Table Products & Services of Teva Pharmaceutical Industries
21.Table Products & Services of MSN Laboratories
22.Table Products & Services of Cadila Pharmaceuticals
23.Table Products & Services of LGM Pharma
24.Table Products & Services of Bal Pharma
25.Table Products & Services of Changzhou Pharmaceutical Factory
26.Table Products & Services of Jingxin Pharm
27.Table Products & Services of Zhejiang Hisun Pharmaceutical
28.Table Products & Services of HEC Pharm
29.Table Products & Services of Lunan Pharmaceutical
30.Table Products & Services of Nanjing Frochem Tech
31.Table Products & Services of Lianyungang Runzhong Pharmaceutical
32.Table Products & Services of Shandong Bechem Chemicals
33.Table Products & Services of CTX Life Sciences
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global D-Mannose Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global D-Mannose Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global D-Mannose Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global D-Mannose Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global D-Mannose Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global D-Mannose Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global D-Mannose Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global D-Mannose Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global D-Mannose Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global D-Mannose Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global D-Mannose Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Purity 98.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Purity 99.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Tablet (including dispersible tablet and general tablet) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Purity 98.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Purity 99.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Tablet (including dispersible tablet and general tablet) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Purity 98.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Purity 99.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Tablet (including dispersible tablet and general tablet) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Purity 98.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Purity 99.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Tablet (including dispersible tablet and general tablet) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Purity 98.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Purity 99.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Tablet (including dispersible tablet and general tablet) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Purity 98.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Purity 99.0% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Tablet (including dispersible tablet and general tablet) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure D-Mannose Sales Revenue (Million USD) of AstraZeneca 2017-2020e
72.Figure D-Mannose Sales Revenue (Million USD) of Teva Pharmaceutical Industries 2017-2020e
73.Figure D-Mannose Sales Revenue (Million USD) of MSN Laboratories 2017-2020e
74.Figure D-Mannose Sales Revenue (Million USD) of Cadila Pharmaceuticals 2017-2020e
75.Figure D-Mannose Sales Revenue (Million USD) of LGM Pharma 2017-2020e
76.Figure D-Manno


More Publications